Company: HYEX
Filing Date: 2025-04-01
Form Type: 10-K
Source: 0001096906-25-000370
Chunk: 28

Company: HEALTHY EXTRACTS INC.
Filing Date: 2025-04-01
Form: 10-K
Item: Item 7
Chunk 28
---
 ended December 31, 2023 was $35,000. We have both short- and medium-term cash needs. We anticipate that these needs will be satisfied through increased revenues and the issuance of debt or the sale of our securities until such time as our cash flows from operations will consistently satisfy our cash flow needs. 

Our cash, current assets, total assets, and current and total liabilities as of December 31, 2024 and 2023 were as follows:

December 31,
 
December 31,
 
Increase/

2024
 
2023
 
(Decrease)

Cash
$
112,020
 
$
19,441
 
$ 
92,579

Total Current Assets
1,642,498

1,899,678
 
(257,180)

Total Assets
2,377,973

2,635,014
 
(257,041)

Total Current and Total Liabilities
1,967,596

1,680,424
 
287,172

Our total current assets and total assets decreased slightly during the year ended December 31, 2024 primarily as a result of our decrease in inventory of $265,067, offset in part by an increase in cash of $92,579. Our accumulated deficit increased during the year ended December 31, 2024, by $840,671 to $19,240,344.

In order to repay our obligations in full or in part when due, we will be required to raise significant capital from other sources. There is no assurance, however, that we will be successful in these efforts.

Cash Requirements

Our cash on hand as of December 31, 2024 was $112,020. Based on our current level of revenues and monthly burn rate for 2023 of approximately $35,000 per month, we will need to continue to fund operations by raising capital from the sale of our stock and debt financings.

Sources and Uses of Cash 

Operating Activities

We had net cash from operating activities of $281,968 for the year ended December 31, 2024, compared to net cash used in operating activities of $(415,749) for the year ended December 31, 2023. We use our cash for normal business operations. Our net cash from operating activities for the year ended December 31, 2024 consisted of our net loss of $840,671, offset in part by our change in fair value on derivative liability of $471,270, warrants issued for